FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lupin Pharmaceuticals Lisinopril Tablets Recall

Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Phar…

Lupin Pharmaceuticals Inc. · Baltimore, MD

Risk level
Class II
Reported by FDA
Apr 29, 2020
Recall ID
D-1250-2020
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled Lisinopril Tablets starting Apr 20, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1250-2020 on Apr 29, 2020. Reason: Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles. Status: Terminated.

Why it was recalled

Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.

Product description

Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03

Lot numbers, UPCs & expiration codes

Lot # Q000255, Exp 01/2022

Where it was sold

Product was distributed Nationwide in the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1250-2020
Classification
Class II
Status
Terminated
Recall initiated
Apr 20, 2020
FDA report date
Apr 29, 2020
Quantity
11,808 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1250-2020, exactly as published.

Show all FDA fields
City
Baltimore
State
MD
Status
Terminated
Country
United States
Event ID
85511
Address
Harborplace Tower
Address (line 2)
111 S Calvert St Fl 21st
Code information
Lot # Q000255, Exp 01/2022
Postal code
21202-6174
Report date
Apr 29, 2020
Product type
Drugs
Recall number
D-1250-2020
Classification
Class II
Recalling firm
Lupin Pharmaceuticals Inc.
Product quantity
11,808 bottles
Termination date
Jun 7, 2021
Reason for recall
Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03
Distribution pattern
Product was distributed Nationwide in the United States.
Recall initiation date
Apr 20, 2020
Initial firm notification
Letter
Center classification date
Apr 21, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1250-2020, published Apr 29, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls